The Impact of NAD Bioavailability on DNA Double-Strand Break Repair Capacity in Human Dermal Fibroblasts after Ionizing Radiation

Cells. 2023 May 31;12(11):1518. doi: 10.3390/cells12111518.

Abstract

Nicotinamide adenine dinucleotide (NAD) serves as a substrate for protein deacetylases sirtuins and poly(ADP-ribose) polymerases, which are involved in the regulation of DNA double-strand break (DSB) repair molecular machinery by various mechanisms. However, the impact of NAD bioavailability on DSB repair remains poorly characterized. Herein, using immunocytochemical analysis of γH2AX, a marker for DSB, we investigated the effect of the pharmacological modulation of NAD levels on DSB repair capacity in human dermal fibroblasts exposed to moderate doses of ionizing radiation (IR). We demonstrated that NAD boosting with nicotinamide riboside did not affect the efficiency of DSB elimination after the exposure of cells to IR at 1 Gy. Moreover, even after irradiation at 5 Gy, we did not observe any decrease in intracellular NAD content. We also showed that, when the NAD pool was almost completely depleted by inhibition of its biosynthesis from nicotinamide, cells were still able to eliminate IR-induced DSB, though the activation of ATM kinase, its colocalization with γH2AX and DSB repair capacity were reduced in comparison to cells with normal NAD levels. Our results suggest that NAD-dependent processes, such as protein deacetylation and ADP-ribosylation, are important but not indispensable for DSB repair induced by moderate doses of IR.

Keywords: DNA double-strand break repair; human dermal fibroblasts; ionizing radiation; nicotinamide adenine dinucleotide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Availability
  • DNA / metabolism
  • Fibroblasts / metabolism
  • Humans
  • NAD* / metabolism
  • Poly(ADP-ribose) Polymerases / metabolism
  • Radiation, Ionizing*

Substances

  • NAD
  • Poly(ADP-ribose) Polymerases
  • DNA

Grants and funding

The research was carried out within the state assignment of the Ministry of Science and Higher Education of the Russian Federation (theme № FMFU-2021-0004). Experiments on pharmacological modulation of NAD levels and NAD quantification were supported by the Russian Science Foundation (grant № 21-14-00319).